Showing results (71-80 of 404) with videos related to
Sort By:
Pageof 41
The American Journal of Cardiology|November 11, 1998
Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trialH D WhiteThe American Journal of Cardiology|December 5, 1991
Comparative safety of thrombolytic agentsH D WhiteCardiovascular Drugs and Therapy|April 1, 1997
Is heparin of value in the management of acute myocardial infarction?H D WhiteThe Journal of Biological Chemistry|January 25, 1985
Kinetics of tryptophan fluorescence enhancement in myofibrils during ATP hydrolysisH D WhiteThe American Journal of Cardiology|May 1, 1987
Need for better severity indexes of acute myocardial infarction under diagnosis-related groupsG I Barbash, C Safran, B J Ransil, et al.Diabetes Care|September 1, 1985
The incidence of insulin-dependent diabetes mellitus in Israeli children and adolescents 0-20 years of age: a retrospective study, 1975-1980Z V Laron, M Karp, M ModanObstetrics and Gynecology|March 1, 1980
Prospective follow-up of patients with hydatidiform moleJ Menczer, M Modan, D M SerrFundamental & Clinical Pharmacology|January 1, 1989
Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertensionJ Shohat, M Modan, J B RosenfeldAmerican Heart Journal|July 1, 1991
Incidence of left ventricular thrombi formation after thrombolytic therapy with recombinant tissue plasminogen activator, heparin, and aspirin in patients with acute myocardial infarctionM Motro, G I Barbash, H Hod, et al.Pageof 41